Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, May 12, 2022
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
Tiago Fauth Maintained (ASND) at Buy with Decreased Target to $123 on, May 12th, 2022
Tiago Fauth of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $194 to $123 on, May 12th, 2022.
Tiago has made no other calls on ASND in the last 4 months.
There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 0 agree with Tiago's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Tiago
- Tazeen Ahmad of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $161 on, Tuesday, March 15th, 2022
- Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $117 on, Thursday, March 3rd, 2022
- Leland Gershell of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $170 on, Monday, February 14th, 2022
